Popli R, Sahaf B, Nakasone H, Lee J, Miklos D
Immunol Res. 2014; 58(2-3):249-58.
PMID: 24781195
PMC: 4380433.
DOI: 10.1007/s12026-014-8514-3.
Martinez C, Smith J, Blaese M, GOOD R
J Exp Med. 1963; 118:743-58.
PMID: 14087619
PMC: 2137681.
DOI: 10.1084/jem.118.5.743.
Calne R
Postgrad Med J. 1962; 38:548-59.
PMID: 14017937
PMC: 2482139.
DOI: 10.1136/pgmj.38.444.548.
Stark R
Bull N Y Acad Med. 1958; 34(9):561-77.
PMID: 13573026
PMC: 1805981.
Woodruff M
Klin Wochenschr. 1958; 36(6):245-54.
PMID: 13540162
DOI: 10.1007/BF01479197.
Bibliography of human genetics.
Post R
Am J Hum Genet. 1958; 10(2):235-48.
PMID: 13533398
PMC: 1931935.
Analysis of haplotype preference in the cytotoxic T-cell response to H-Y.
Brenan M, Simpson E, Mullbacher A
Immunogenetics. 1981; 13(1-2):133-46.
PMID: 6971801
DOI: 10.1007/BF00524611.
Non-H-2 and H-2-linked immune response genes control the cytotoxic T-cell response to H-Y.
Fierz W, Brenan M, Mullbacher A, Simpson E
Immunogenetics. 1982; 15(3):261-70.
PMID: 6802751
DOI: 10.1007/BF00364334.
Effects of 2-BR-alpha-ergokryptine (CB 154) on sex-linked rejection of pituitary isografts in female C57BL mice.
Hoshino K
Experientia. 1973; 29(7):882-4.
PMID: 4146807
DOI: 10.1007/BF01946344.
The capacity of fetal and neonatal renal tissues to regenerate and differentiate in a heterotopic allogeneic subcutaneous tissue site in the rat.
Barakat T, HARRISON R
J Anat. 1971; 110(Pt 3):393-407.
PMID: 4112255
PMC: 1271052.
Potentiation of T-cell mediated immunity by levamisole.
Renoux G, Renoux M, TELLER M, McMahon S, Guillaumin J
Clin Exp Immunol. 1976; 25(2):288-96.
PMID: 782749
PMC: 1541355.
Effects of BCG, levamisole and PS-K on the rejection of male skin grafts by female mice.
Seo S, Yasuhara J, Saeki K
Agents Actions. 1979; 9(4):344-9.
PMID: 391007
DOI: 10.1007/BF01970659.
